🔎 Trials Near Me

Beranda › Kanker Rahim › California

Uji klinis Kanker Rahim di California

9 studi untuk Kanker Rahim mencari peserta di lokasi di California.

Kota di California

Teks studi resmi (Bahasa Inggris)

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
Menerima pesertaFase 4
Usia 18 ke atas · Wanita · Diperbarui 25 Sep 2026 · NCT06952660

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

  • Research Site, Duarte
  • Research Site, Irvine
  • Research Site, La Jolla
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 3 Sep 2026 · NCT06989112

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

  • City of Hope Medical Center, Duarte
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT04329494

Investigations of Reproductive Cancers in Women

  • Sutter Health, San Carlos
Menerima pesertaStudi observasional
Usia 45 hingga 100 · Wanita · Diperbarui 17 Agu 2026 · NCT06527157

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  • University of California Los Angeles Medical Center, Los Angeles
  • University of California, San Diego; Moores Cancer Center, San Diego
  • USOR Sansum Clinic, Santa Barbara
  • dan 1 lainnya
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT05579366

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

  • Research Site, La Jolla
  • Research Site, Orange
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 29 Jul 2026 · NCT07044336

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • Precision NextGen Oncology & Research Center, Beverly Hills
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
  • University of California Los Angeles Rheumatology, Westwood, Los Angeles
Menerima pesertaFase 2
Usia 8 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT05503797

Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer

  • University of California, San Francisco, San Francisco
Menerima pesertaFase 1
Usia 18 ke atas · Wanita · Diperbarui 11 Des 2025 · NCT06795009

Molecular and Cellular Profiling of Uterine Lavage Collected During Gynecologic Surgery

  • Stanford University, Palo Alto
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Nov 2025 · NCT07044505

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.